SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Artemis Therapeutics, Inc. – ‘S-1’ on 9/21/22 – ‘EX-23.1’

On:  Wednesday, 9/21/22, at 4:03pm ET   ·   Accession #:  1178913-22-3487   ·   File #:  333-267534

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 11/21/22   ·   Latest:  ‘S-1/A’ on 1/4/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/21/22  Artemis Therapeutics, Inc.        S-1                   56:5.7M                                   Z-K Global Ltd./FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.89M 
 2: EX-10.8     Form of Indemnification Agreement                   HTML     54K 
 3: EX-23.1     Consent of Expert or Counsel -- exhibit_23-1        HTML     16K 
 4: EX-FILING FEES  Calculation of Filing Fee Tables                HTML     24K 
10: R1          Document and Entity Information                     HTML     29K 
11: R2          Interim Condensed Consolidated Balance Sheets       HTML    135K 
12: R3          Interim Condensed Consolidated Balance Sheets       HTML     40K 
                (Parenthetical)                                                  
13: R4          Interim Condensed Consolidated Statements of        HTML     85K 
                Comprehensive Loss (Unaudited)                                   
14: R5          Interim Condensed Statements of Stockholders'       HTML     85K 
                Equity (Unaudited)                                               
15: R6          Interim Condensed Consolidated Statement of Cash    HTML     86K 
                Flows (Unaudited)                                                
16: R7          Description of Business and General                 HTML     31K 
17: R8          Summary of Significant Accounting Policies          HTML     56K 
18: R9          Inventories                                         HTML     34K 
19: R10         Commitments and Contingencies                       HTML     22K 
20: R11         Property and Equipment, Net                         HTML     36K 
21: R12         Intangibles, Net                                    HTML     28K 
22: R13         Leases                                              HTML     71K 
23: R14         Stockholders' Equity                                HTML     36K 
24: R15         Related Party Balances and Transactions             HTML     55K 
25: R16         Tax on Income                                       HTML     37K 
26: R17         Subsequent Events                                   HTML     21K 
27: R18         Summary of Significant Accounting Policies          HTML     96K 
                (Policies)                                                       
28: R19         Summary of Significant Accounting Policies          HTML     21K 
                (Tables)                                                         
29: R20         Inventories (Tables)                                HTML     33K 
30: R21         Leases (Tables)                                     HTML     67K 
31: R22         Property and Equipment, Net (Tables)                HTML     34K 
32: R23         Intangibles, Net (Tables)                           HTML     27K 
33: R24         Tax on Income (Tables)                              HTML     28K 
34: R25         Related Party Balances and Transactions (Tables)    HTML     46K 
35: R26         Description of Business and General (Narrative)     HTML     43K 
                (Details)                                                        
36: R27         Summary of Significant Accounting Policies          HTML     24K 
                (Details)                                                        
37: R28         Inventories (Details)                               HTML     23K 
38: R29         Property and Equipment, Net (Details)               HTML     30K 
39: R30         Property and Equipment, Net (Narrative) (Details)   HTML     19K 
40: R31         Intangibles, Net (Details)                          HTML     27K 
41: R32         Commitments and Contingencies (Narrative)           HTML     24K 
                (Details)                                                        
42: R33         Leases (Details)                                    HTML     21K 
43: R34         Leases (Details 1)                                  HTML     27K 
44: R35         Leases (Details 2)                                  HTML     29K 
45: R36         Stockholders' Equity (Narrative) (Details)          HTML     64K 
46: R37         Related Party Balances and Transactions (Details)   HTML     20K 
47: R38         Related Party Balances and Transactions (Details    HTML     24K 
                1)                                                               
48: R39         Related Party Balances and Transactions             HTML     27K 
                (Narrative) (Details)                                            
49: R40         Tax on Income (Schedule of Deferred Income Taxes)   HTML     25K 
                (Details)                                                        
50: R41         Tax on Income (Narrative) (Details)                 HTML     28K 
51: R42         Subsequent Events (Narrative) (Details)             HTML     35K 
54: XML         IDEA XML File -- Filing Summary                      XML     98K 
52: XML         XBRL Instance -- zk2228396_htm                       XML   1.01M 
53: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
 6: EX-101.CAL  XBRL Calculations -- atms-20220630_cal               XML     95K 
 7: EX-101.DEF  XBRL Definitions -- atms-20220630_def                XML    261K 
 8: EX-101.LAB  XBRL Labels -- atms-20220630_lab                     XML   1.13M 
 9: EX-101.PRE  XBRL Presentations -- atms-20220630_pre              XML    475K 
 5: EX-101.SCH  XBRL Schema -- atms-20220630                         XSD    121K 
55: JSON        XBRL Instance as JSON Data -- MetaLinks              261±   358K 
56: ZIP         XBRL Zipped Folder -- 0001178913-22-003487-xbrl      Zip    460K 


‘EX-23.1’   —   Consent of Expert or Counsel — exhibit_23-1


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the use in this Registration Statement on Form S-1 of our report dated July 5, 2022, except for Note 1B, as to which the date is September 6, 2022, relating to the financial statements of Artemis Therapeutics Inc. (operating as Manuka Ltd. prior to the reorganization). We also consent to the reference to us under the heading "Experts" in such Registration Statement.
 
Certified Public Accountants
A Firm in the Deloitte Global Network
 
Tel Aviv, Israel
 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1’ Filing    Date    Other Filings
Filed on:9/21/22
9/6/22
7/5/228-K
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/22  Manuka, Inc.                      S-1/A                 58:6.1M                                   Z-K Global Ltd./FA


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/09/22  Manuka, Inc.                      8-K:5,9     9/08/22   11:172K                                   Z-K Global Ltd./FA
 7/05/22  Manuka, Inc.                      8-K:1,2,3,5 6/30/22   21:2.4M                                   Z-K Global Ltd./FA
 5/23/22  Manuka, Inc.                      10-Q        3/31/22   43:2.6M                                   Z-K Global Ltd./FA
 9/24/10  Artemis Therapeutics, Inc.        8-K:5,9     9/24/10    5:52K                                    Z-K Global Ltd./FA
Top
Filing Submission 0001178913-22-003487   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:09:39.2pm ET